Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Joseph Rigano"'
Publikováno v:
International Journal of Laboratory Hematology. 42:41-48
We aimed to review the interfering effect of DOACs on tests for haemostatic function and then to discuss overcoming these with activated carbon (AC) products, thereby eliminating DOAC issues from test plasmas. Recent relevant articles were reviewed a
Autor:
Wai Khoon Ho, Joseph Rigano
Publikováno v:
Journal of Thrombosis and Thrombolysis. 49:446-450
The anti-phospholipid syndrome (APS) is defined by the laboratory detection of at least one of three anti-phospholipid autoantibodies (lupus anticoagulant, or anti-cardiolipin or anti-β2-glycoprotein I antibodies) in the clinical setting of thrombos
Autor:
Nadia Hussain, Claire Pouplard, Will Thomas, Paul O Jones, Joseph Rigano, Gary W. Moore, Elaine Gray, Katrien Devreese, Sean Platton, Danielle White
Publikováno v:
Journal of thrombosis and haemostasis : JTHREFERENCES. 19(12)
Background Lupus anticoagulant (LA) assays are compromised in anticoagulated patients, and existing strategies to overcome the interferences have limitations. The prothrombin-activating Taipan snake venom time (TSVT) screening test and ecarin time (E
Autor:
Joseph Rigano, Wai Khoon Ho
Publikováno v:
International journal of laboratory hematologyREFERENCES. 43(5)
Introduction The antiphospholipid syndrome (APS) is characterized by thrombosis or pregnancy morbidity, and the detection in the blood of at least one of three antiphospholipid antibodies (lupus anticoagulant, or anticardiolipin or anti-β2 -glycopro
Autor:
Prahlad Ho, Mark Tacey, Hui Yin Lim, Harshal Hanumant Nandurkar, Cheryl Ng, Joseph Rigano, Geoffrey A. Donnan
Publikováno v:
Blood Coagulation & Fibrinolysis. 29:300-306
Myeloproliferative neoplasms (MPN) are independent risks for thrombotic events. Routine laboratory tests are inadequate to evaluate the underlying procoagulant state. Global coagulation assays such as thromboelastography, thrombin and fibrin generati
Autor:
Mark Tacey, Prahlad Ho, Joseph Rigano, Cheryl Ng, Geoffrey A. Donnan, Carole L. Smith, Harshal Hanumant Nandurkar
Publikováno v:
Thrombosis Research. 154:80-83
Publikováno v:
Blood coagulationfibrinolysis : an international journal in haemostasis and thrombosis. 29(2)
Direct oral anticoagulants (DOACs) are increasingly being used, primarily due to their drug stability and patient convenience. Although these drugs have been evaluated to be well tolerated in numerous clinical trials, their impact on in-vivo anticoag
Autor:
Wai Khoon Ho, Joseph Rigano
Publikováno v:
Pathology. 50:580-581